✦ LIBER ✦

NF-κB in critical diseases: a bad guy?

✍ Scribed by Uwe Senftleben

Book ID: 105833354
Publisher: Springer
Year: 2003
Tongue: English
Weight: 146 KB
Volume: 29
Category: Article
ISSN: 1432-1238
DOI: 10.1007/s00134-003-1932-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NF-κB-related genetic diseases

✍ Courtois, G; Smahi, A 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 215 KB

NF-κB in inflammatory bowel disease

✍ I. Atreya; R. Atreya; M. F. Neurath 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

NF-κB in liver diseases: a target for dr

NF-κB in liver diseases: a target for drug therapy

✍ Pablo Muriel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

## Abstract There are five nuclear factor‐__κ__B (NF‐__κ__B) transcription factors with important roles in innate immunity, liver inflammation, fibrosis and apoptosis prevention. Several inhibitors of NF‐__κ__B, like caffeic acid, captopril, curcumin, pyrrolidine dithiocarbamate, resveratrol, silym

NF-κB, a pivotal transcription factor in

NF-κB, a pivotal transcription factor in silica-induced diseases

✍ Fei Chen; Xianglin Shi 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 156 KB

Blocking NF-κB in the liver: The good an

Blocking NF-κB in the liver: The good and bad news

✍ Rebecca Taub 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

NF-κB signaling in skeletal muscle: pros

NF-κB signaling in skeletal muscle: prospects for intervention in muscle diseases

✍ Foteini Mourkioti; Nadia Rosenthal 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 437 KB